-Reuters
Related Posts
Myriad Genetics 8-K Shows Co. Settled Qui Tam Suit Filed By STF LLC Against Co.’s Crescendo Bio Subsidiary, Co. To Pay $45.25M
On April 1, 2022, Myriad Genetics, Inc. (the “Company”) settled the qui tam lawsuit that was filed by STF, LLC (“Relator”) against Crescendo Bioscience, LLC (formerly known as Crescendo
Centerra Gold Q3 EPS $(0.06) Beats $(0.08) Estimate, Sales $179.01M Down From $220.56M YoY
Centerra Gold (NYSE:CGAU) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 150 percent decrease over earnings of $0.12 per share from the same
Triton Gains On Q2 Earnings Beat; Declares Dividend
Triton International Ltd (NYSE:TRTN) reported second-quarter FY22 total leasing revenue growth of 14% year-over-year to $421.61 million, marginally beating the…